Healthcare provider profile · identity verified

Andrew D Peltier, MD

Internal Medicine · CAMBRIDGE, MN · NPI 1457686792

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	526	141
Losartan Potassium	Losartan Potassium	413	111
Levothyroxine Sodium	Levothyroxine Sodium	377	99
Rosuvastatin Calcium	Rosuvastatin Calcium	350	108
Lisinopril	Lisinopril	348	90
Amlodipine Besylate	Amlodipine Besylate	323	95
Omeprazole	Omeprazole	318	94
Furosemide	Furosemide	289	68
Metoprolol Succinate	Metoprolol Succinate	269	75
Gabapentin	Gabapentin	256	69
Warfarin Sodium	Warfarin Sodium	243	43
Duloxetine Hcl	Duloxetine Hcl	198	44
Trazodone Hcl	Trazodone Hcl	178	50
Metformin Hcl Er	Metformin Hcl	165	43
Hydrochlorothiazide	Hydrochlorothiazide	161	44
Eliquis	Apixaban	157	35
Fluticasone Propionate	Fluticasone Propionate	154	71
Allopurinol	Allopurinol	148	39
Metoprolol Tartrate	Metoprolol Tartrate	146	38
Tamsulosin Hcl	Tamsulosin Hcl	143	43
Pantoprazole Sodium	Pantoprazole Sodium	138	37
Spironolactone	Spironolactone	128	36
Metformin Hcl	Metformin Hcl	125	33
Sertraline Hcl	Sertraline Hcl	118	27
Escitalopram Oxalate	Escitalopram Oxalate	117	28
Potassium Chloride	Potassium Chloride	112	38
Albuterol Sulfate Hfa	Albuterol Sulfate	110	53
Carvedilol	Carvedilol	106	32
Pregabalin	Pregabalin	105	23
Oxycodone Hcl	Oxycodone Hcl	103	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	93	27
Baclofen	Baclofen	92	21
Glipizide	Glipizide	87	23
Atenolol	Atenolol	81	22
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	79	15
Triamcinolone Acetonide	Triamcinolone Acetonide	78	36
Simvastatin	Simvastatin	75	22
Ropinirole Hcl	Ropinirole Hcl	74	20
Clopidogrel	Clopidogrel Bisulfate	71	23
Ozempic	Semaglutide	70	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	69	17
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	21
Famotidine	Famotidine	63	13
Alendronate Sodium	Alendronate Sodium	61	17
Torsemide	Torsemide	61	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	61	12
Mirtazapine	Mirtazapine	60	13
Prednisone	Prednisone	57	29
Venlafaxine Hcl Er	Venlafaxine Hcl	57	15
Jardiance	Empagliflozin	52	16
Xarelto	Rivaroxaban	52	18
Montelukast Sodium	Montelukast Sodium	51	14
Mounjaro	Tirzepatide	51	13
Trulicity	Dulaglutide	51	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	50	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	48	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	17
Quetiapine Fumarate	Quetiapine Fumarate	47	suppressed
Donepezil Hcl	Donepezil Hcl	45	11
Propranolol Hcl	Propranolol Hcl	45	12
Pravastatin Sodium	Pravastatin Sodium	44	12
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Ezetimibe	Ezetimibe	43	13
Myrbetriq	Mirabegron	41	12
Suboxone	Buprenorphine Hcl/Naloxone Hcl	39	suppressed
Glipizide Er	Glipizide	36	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	14
Tramadol Hcl	Tramadol Hcl	36	suppressed
Rybelsus	Semaglutide	34	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	33	suppressed
Finasteride	Finasteride	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Valsartan	Valsartan	31	suppressed
Buspirone Hcl	Buspirone Hcl	30	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	11
Nystatin	Nystatin	30	15
Tizanidine Hcl	Tizanidine Hcl	30	12
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	29	suppressed
Cephalexin	Cephalexin	29	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	12
Nifedipine Er	Nifedipine	29	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	29	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	11
Novolog Flexpen	Insulin Aspart	28	11
Chlorthalidone	Chlorthalidone	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	14
Doxycycline Monohydrate	Doxycycline Monohydrate	25	19
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Methadone Hcl	Methadone Hcl	24	suppressed
Nitroglycerin	Nitroglycerin	23	20
Ondansetron Odt	Ondansetron	22	14
Topiramate	Topiramate	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Galantamine Hbr	Galantamine Hbr	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Easy Touch Pen Needle	Pen Needle, Diabetic	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Epinephrine	Epinephrine	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Clonidine	Clonidine	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Naproxen	Naproxen	13	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	13	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Azithromycin	Azithromycin	12	suppressed
Bumetanide	Bumetanide	12	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	12	suppressed
Digoxin	Digoxin	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Naratriptan Hcl	Naratriptan Hcl	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Testosterone Cypionate	Testosterone Cypionate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error